Abstracts tagged "fibromyalgia and physical therapy"

Abstract Number: 2297 • 2015 ACR/ARHP Annual Meeting
Dinamyx Neuromodulation in Fibromyalgia
CAMILLO GIACOMELLI, Antonino Santagati, Arianna Consensi, Alessandra Rossi and Laura Bazzichi, Division of Reumatology, Univeristy of Pisa, Pisa, Italy
Background/Purpose: Fibromyalgia (FM) is one of the most common diseases manifested by pain, tenderness and fatigue. FM is still a disorder of unknown etiology that…
Abstract Number: 1107 • 2013 ACR/ARHP Annual Meeting
A Randomized Trial Of a Physical Self-Management Program For Fibromyalgia Syndrome
Aline Ranzolin¹, Suélem S. Barros², Vanessa M. Fernandes³, Eduardo A. S. Pimentel³, Claudia Diniz L. Marques⁴ and Angela Luzia B. Pinto Duarte⁵, ¹Rheumatology, Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, ²Programa de Pós-Graduação em Ciências da Saúde da Universidade Federal de Pernambuco, Recife, Brazil, ³Centro Universitário Maurício de Nassau, Recife, Brazil, ⁴Disciplina de Reumatologia, Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, ⁵Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil
Background/Purpose: Fibromyalgia syndrome (FMS) is a painful disorder that interferes directly in the functional capacity and quality of life. Treatment advocates interventions in the physical,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].